New York Times reports on a project set to kick off in the next few months in which three medical research centers -- the University of Michigan Comprehensive Cancer Center, Dana-Farber Cancer Institute, and Baylor College of Medicine -- will begin testing patients for the presence of cancerous stem cells to see if there's hope for therapeutically targeting them in the future.